Dr. Zhang has been leading EXUMA’s Asia team since 2016 and currently serves as Vice President of Alliance Management and Operations.  Prior to EXUMA, she was Head of Biologics at BioDuro and held roles at Wuxi Apptec and aTyr Pharma Inc..  She served as the key scientist leading the in vitro assay development efforts while exploring the MOAs for the novel therapeutic Physiocrines.  She was also responsible for establishing SOPs of release assays using human primary cells and tissues for leading candidates and evaluating CROs in Asia.

Dr. Zhang came to San Diego for her postdoctoral training at the Scripps Research Institute following her Ph.D. in molecular microbiology from the Chinese Academy of Sciences.